Page 184 - MI-2-3

Microbes & Immunity A novel anti-EphB2 monoclonal antibody for flow cytometry

26. Janes PW, Vail ME, Gan HK, Scott AM. Antibody targeting 37. Batlle E, Henderson JT, Beghtel H, et al. Beta-catenin and
of eph receptors in cancer. Pharmaceuticals (Basel). TCF mediate cell positioning in the intestinal epithelium
2020;13(5):88. by controlling the expression of EphB/ephrinB. Cell.
doi: 10.3390/ph13050088 2002;111(2):251-263.
27. Buckens OJ, El Hassouni B, Giovannetti E, Peters GJ. The doi: 10.1016/s0092-8674(02)01015-2
role of Eph receptors in cancer and how to target them: 38. Cortina C, Palomo-Ponce S, Iglesias M, et al. EphB-
Novel approaches in cancer treatment. Expert Opin Investig ephrin-B interactions suppress colorectal cancer
Drugs. 2020;29(6):567-582. progression by compartmentalizing tumor cells. Nat Genet.
doi: 10.1080/13543784.2020.1762566 2007;39(11):1376-1383.
28. Saha N, Robev D, Mason EO, Himanen JP, Nikolov DB. doi: 10.1038/ng.2007.11
Therapeutic potential of targeting the Eph/ephrin signaling 39. Jubb AM, Zhong F, Bheddah S, et al. EphB2 is a
complex. Int J Biochem Cell Biol. 2018;105:123-133. prognostic factor in colorectal cancer. Clin Cancer Res.
doi: 10.1016/j.biocel.2018.10.006 2005;11(14):5181-5187.
29. Taki S, Kamada H, Inoue M, et al. A novel bispecific doi: 10.1158/1078-0432.Ccr-05-0143
antibody against human CD3 and ephrin receptor A10 for 40. Takei J, Kaneko MK, Ohishi T, Kawada M, Harada H, Kato Y.
breast cancer therapy. PLoS One. 2015;10(12):e0144712. A novel anti-EGFR monoclonal antibody (EMab-17) exerts
doi: 10.1371/journal.pone.0144712 antitumor activity against oral squamous cell carcinomas via
antibody-dependent cellular cytotoxicity and complement-
30. Zhou F, Wang B, Wang H, et al. circMELK promotes dependent cytotoxicity. Oncol Lett. 2020;19(4):2809-2816.
glioblastoma multiforme cell tumorigenesis through the
miR-593/EphB2 axis. Mol Ther Nucleic Acids. 2021;25:25-36. doi: 10.3892/ol.2020.11384
doi: 10.1016/j.omtn.2021.05.002 41. Kato Y, Ohishi T, Sano M, et al. H(2)Mab-19 anti-
human epidermal growth factor receptor 2 monoclonal
31. Lam S, Wiercinska E, Teunisse AF, Lodder K, Ten Dijke P, antibody therapy exerts antitumor activity in pancreatic
Jochemsen AG. Wild-type p53 inhibits pro-invasive cancer xenograft models. Monoclon Antib Immunodiagn
properties of TGF-β3 in breast cancer, in part through
regulation of EPHB2, a new TGF-β target gene. Breast Immunother. 2020;39(3):61-65.
Cancer Res Treat. 2014;148(1):7-18. doi: 10.1089/mab.2020.0011
doi: 10.1007/s10549-014-3147-8 42. Asano T, Ohishi T, Takei J, et al. AntiHER3 monoclonal
antibody exerts antitumor activity in a mouse model of
32. Leung HW, Leung CON, Lau EY, et al. EPHB2 Activates
β-catenin to enhance cancer stem cell properties and drive colorectal adenocarcinoma. Oncol Rep. 2021;46(2):173.
sorafenib resistance in hepatocellular carcinoma. Cancer doi: 10.3892/or.2021.8124
Res. 2021;81(12):3229-3240.
43. Nanamiya R, Suzuki H, Kaneko MK, Kato Y. Development
doi: 10.1158/0008-5472.Can-21-0184 of an Anti-EphB4 monoclonal antibody for multiple
33. Nakada M, Niska JA, Miyamori H, et al. The phosphorylation applications against breast cancers. Monoclon Antib
of EphB2 receptor regulates migration and invasion of Immunodiagn Immunother. 2023;42(5):166-177.
human glioma cells. Cancer Res. 2004;64(9):3179-3185. doi: 10.1089/mab.2023.0015
doi: 10.1158/0008-5472.can-03-3667 44. Qiu W, Song S, Chen W, Zhang J, Yang H, Chen Y. Hypoxia-
34. Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME. induced EPHB2 promotes invasive potential of glioblastoma.
EphB2/R-Ras signaling regulates glioma cell adhesion, Int J Clin Exp Pathol. 2019;12(2):539-548.
growth, and invasion. Am J Pathol. 2005;167(2):565-576. 45. Genander M, Halford MM, Xu NJ, et al. Dissociation of EphB2
doi: 10.1016/s0002-9440(10)62998-7 signaling pathways mediating progenitor cell proliferation
and tumor suppression. Cell. 2009;139(4):679-692.
35. Xi HQ, Wu XS, Wei B, Chen L. Eph receptors and
ephrins as targets for cancer therapy. J Cell Mol Med. doi: 10.1016/j.cell.2009.08.048
2012;16:2894-2909. 46. Mao W, Luis E, Ross S, et al. EphB2 as a therapeutic antibody
doi: 10.1111/j.1582-4934.2012.01612.x drug target for the treatment of colorectal cancer. Cancer
Res. 2004;64(3):781-788.
36. Holmberg J, Genander M, Halford MM, et al. EphB receptors
coordinate migration and proliferation in the intestinal stem doi: 10.1158/0008-5472.can-03-1047
cell niche. Cell. 2006;125(6):1151-1163.
47. Sano M, Kaneko MK, Aasano T, Kato Y. Epitope mapping
doi: 10.1016/j.cell.2006.04.030 of an antihuman EGFR monoclonal antibody (EMab-134)

Volume 2 Issue 3 (2025) 176 doi: 10.36922/mi.5728